Catalent Launches FastChain Service
News Jun 30, 2016
Catalent Pharma Solutions has announced the launch of its FastChain™ service, for greater speed, flexibility and efficiency in the management of global clinical supplies. Based upon the company’s demand led supply model, FastChain is a continuous GMP approach to clinical supply management that decouples primary packaging from secondary packaging, and enables the final assembly, labeling and distribution of clinical supplies on a regional basis.
This approach reduces the need to pre-package bulk supplies far in advance of the study start, creates the ability to pool supplies across protocols, and has the potential to reduce clinical waste from upwards of 200% or more to less than 20%. Investigator sites will receive only the clinical supplies they need to meet actual patient demand within a matter of days rather than weeks. Furthermore, mid-study changes such as revised dosing schedules or the addition of countries and clinical sites will be easy to accommodate for FastChain customers.
“Catalent is already performing global demand led supply services on behalf of a major pharmaceutical customer and will now introduce its unique FastChain service to bring demand led supply to the broader industry,” stated Wetteny Joseph, President, Catalent Clinical Supply Services. “We have seen significant interest from companies of all sizes who are looking for more flexible and innovative solutions to get to the clinic faster.”
Catalent will continue to make significant investments in its facilities worldwide to include specialized packaging lanes, and integrated systems and processes to support demand led studies and will make the FastChain service available for both ambient and cold chain studies on a global basis.
PhoreMost and Plexxikon Collaborate to Identify Novel Drug TargetsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has signed a collaborative agreement with Plexxikon Inc., the small molecule structure-guided R&D centre of Daiichi Sankyo.READ MORE
Anti-Malaria Drugs Delivered With CaffeineNews
Many drug delivery systems, such as capsules and tablets, can be difficult to swallow, especially for children. Making delivery systems out of polymer gels is an attractive option, but usually requires hazardous levels of heavy metals to be used. Now, scientists have found a way to build these gels from caffeine molecules.READ MORE
Lonza Opens World’s Largest Dedicated Cell-and-Gene-Therapy Manufacturing Facility in TexasNews
First-of-its-kind, state-of-the-art manufacturing facility with capacity to produce treatment for thousands of patients suffering from rare genetic disorders or life-threatening diseases.READ MORE
Comments | 0 ADD COMMENT
International Conference on Analytical and Bio Analytical Techniques
Oct 31 - Nov 01, 2018